Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03080714 · ClinicalTrials.gov registry record
Triton Agreement and Precision Study
A clinical trial of Eye Diseases and Healthy Eyes, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 88
- Enrollment target
- 1
- Study location
NCT03080714: Completed study of Eye Diseases and Healthy Eyes, sponsored by Topcon Medical Systems.
NCT03080714 is a study of Eye Diseases and Healthy Eyes that has completed, run by Topcon Medical Systems. The registered enrollment target is 88 participants, below the 741,300-participant average among 27 other Eye Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03080714, a study of Eye Diseases and Healthy Eyes, has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
To Compare the agreement and precision between the Topcon DRI OCT Triton and the 3D OCT-1 Maestro with RDB.
Primary Outcome
The thickness of the macula layer
Conditions Studied
Interventions
- DEVICE 3D OCT-1 Maestro
- DEVICE Topcon DRI OCT Triton (plus)
Study Locations (1)
Minnesota
- Fischer Laser Eye Center - Willmar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2017-03-13 |
| Est. Completion | 2017-10-30 |
What the finished NCT03080714 record still lists
NCT03080714 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 741,300-participant average among 27 other Eye Diseases trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Eye Diseases appearing as the primary indexed condition, and to 2 interventions - of which 3D OCT-1 Maestro is the first listed.
NCT03080714 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03080714 about?
NCT03080714 is a clinical study titled "Triton Agreement and Precision Study". To Compare the agreement and precision between the Topcon DRI OCT Triton and the 3D OCT-1 Maestro with RDB.
What is the current status of trial NCT03080714?
This trial is currently completed. The enrollment target is 88 participants. The study started on 2017-03-13. Estimated completion is 2017-10-30.
What conditions does trial NCT03080714 study?
This clinical trial studies the following conditions: Eye Diseases, Healthy Eyes.
What interventions are being tested in trial NCT03080714?
The interventions under investigation include: 3D OCT-1 Maestro (DEVICE), Topcon DRI OCT Triton (plus) (DEVICE).
Who is sponsoring clinical trial NCT03080714?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03080714 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eye Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03080714's enrollment target sits among peer trials
88 13th of 27 higher than 15 of 27 other Eye Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eye Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adaptive Optics Retinal Imaging
RECRUITING
-
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
RECRUITING · Phase 3
-
Widefield Confocal Scanning Laser Ophthalmoscope Optimized for Pediatric and Neonatal Imaging
RECRUITING
-
SGLT2 Inhibitors in Geographic Atrophy
RECRUITING · Phase 2
-
Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
RECRUITING · NA
-
IRIS Registry: Intelligent Research in Sight Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI